CompoAtlas

Glucosamine 300 mg Chondroitin 200 mg

Glucosamine 300 mg Chondroitin 200 mg, NPN 80110701: natural health product licensed in Canada. Medicinal ingredients: Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose, Sulfate de chondroïtine.

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose300 mgNot calculated
Sulfate de chondroïtine

Source : Bos taurus - cartilage

200 mgNot calculated

Non-medicinal ingredients

Gélatine, Glycérine, Poudre de caroube, Huile de soja, Cire d'abeille jaune, Dioxyde de titane, Lécithine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Capsule3 Tous les jours

Uses authorised in Canada

Helps to maintain healthy cartilage/joint health. Helps to relieve (joint) pain associated with osteoarthritis (of the knee).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No warning text available in the imported data.

Product record

Other names
Glucosamine 300 mg Chondroïtine 200 mg, Glucosamine Chondroitin, Glucosamine Chondroitin 500 mg, Glucosamine Chondroïtine, Glucosamine Chondroïtine 500 mg
Licence holder
Wampole Group L.P.
NPN or DIN-HM
80110701
Status
Active licence
Licence date
15 June 2021
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Officinale

Source

Official Health Canada record, licence 80110701

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Glucosamine 300 mg Chondroitin 200 mg (Wampole Group L.P.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80110701-glucosamine-300-mg-chondroitin-200-mg, updated 15 June 2021.

Enter to analyse, Shift+Enter for a new line